Income Statement (TTM)
Hong Kong Pharma Digital Technology Holdings Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2023 03-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
|
|---|---|---|---|---|---|---|
| Revenue | 13 | 17 | 19 | 21 | 21 | 20 |
| Change (%) | 32.91 | 12.23 | 10.90 | -1.10 | -1.11 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 10 | 13 | 15 | 17 | 17 | 18 |
| Change (%) | 33.74 | 13.38 | 11.80 | 3.78 | 3.64 | |
| % of Revenue | 78.19 | 78.68 | 79.48 | 80.12 | 84.07 | 88.11 |
| Gross Operating Profit | 3 | 4 | 4 | 4 | 3 | 2 |
| Change (%) | 29.93 | 8.00 | 7.41 | -20.75 | -26.18 | |
| % of Revenue | 21.81 | 21.32 | 20.52 | 19.88 | 15.93 | 11.89 |
| SG&A | 2 | 2 | 2 | 2 | 2 | 2 |
| Change (%) | 7.47 | -3.01 | -3.10 | 12.39 | 11.02 | |
| % of Revenue | 14.00 | 11.32 | 9.78 | 8.55 | 9.72 | 10.91 |
| R&D | ||||||
| Change (%) | ||||||
| % of Revenue | ||||||
| OpEx | 12 | 15 | 17 | 18 | 19 | 20 |
| Change (%) | 29.74 | 11.31 | 10.16 | 4.64 | 4.43 | |
| % of Revenue | 92.20 | 90.00 | 89.26 | 88.66 | 93.81 | 99.06 |
| Operating Income | 1 | 2 | 2 | 2 | 1 | 0 |
| Change (%) | 70.43 | 20.55 | 17.05 | -45.96 | -85.05 | |
| % of Revenue | 7.80 | 10.00 | 10.74 | 11.34 | 6.19 | 0.94 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | 256.11 | 8.72 | 8.02 | 0.24 | 0.24 | |
| % of Revenue | -0.19 | -0.50 | -0.48 | -0.47 | -0.47 | -0.48 |
| Net Income | 1 | 1 | 2 | 2 | 1 | -0 |
| Change (%) | 33.21 | 21.79 | 17.89 | -50.71 | -102.87 | |
| % of Revenue | 7.95 | 7.97 | 8.65 | 9.19 | 4.58 | -0.13 |
Source: Capital IQ
